Voyager Therapeutics (VYGR) FCF Margin Growth (1y) (2016 - 2026)
Voyager Therapeutics (VYGR) FCF Margin Growth (1y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Voyager Therapeutics |
222.52 Mn |
81.04 Mn |
- |
-69,623.00 |
| Date | Value |
| Mar 31, 2026 |
-69,623.00 |
| Dec 31, 2025 |
3,213.00 |
| Sep 30, 2025 |
-11,864.00 |
| Jun 30, 2025 |
-55,093.00 |
| Mar 31, 2025 |
-88,351.00 |
| Dec 31, 2024 |
-20,584.00 |
| Sep 30, 2024 |
36,003.00 |
| Jun 30, 2024 |
-6,822.00 |
| Mar 31, 2024 |
20,861.00 |
| Dec 31, 2023 |
-87,734.00 |
| Sep 30, 2023 |
-43,451.00 |
| Jun 30, 2023 |
270,223.00 |
| Mar 31, 2023 |
-511,549.00 |
| Dec 31, 2022 |
81,149.00 |
| Sep 30, 2022 |
140,178.00 |
| Jun 30, 2022 |
-102,679.00 |
| Mar 31, 2022 |
552,508.00 |
| Dec 31, 2021 |
42,923.00 |
| Sep 30, 2021 |
-141,654.00 |
| Jun 30, 2021 |
-163,669.00 |